

The purpose of the pump is to interrupt pain signals that travel through the spinal cord. Pain signals which normally travel
to the brain are lessened and pain relief is perceived. Medication is delivered into the intrathecal space surrounding the
spinal cord. The ITP delivers pain medication directly to the pain receptors in the spinal cord and smaller doses of
medication are required to gain relief.
ITP implants are considered when oral pain medications and other methods of pain control have been exhausted or
proven ineffective.
Procedure:
Before an ITP is placed, an intrathecal medication trial is performed. Medication is placed in the spinal fluid. If pain relief
is adequate, an ITP can be permanently placed to control your pain.
Placement of the ITP can be performed in an outpatient setting or in the hospital. The implantation of the device is done
with local anesthesia and sedation (general anesthesia is usually not required). After a sterile scrub, local anesthesia is
used to numb the needle entry location. Once the area is numb, a larger needle and catheter are placed into the
intrathecal space using x-ray guidance.
Once the catheter is in the proper location, the pump is then connected and placed under the skin on the lower part of
your abdomen. The catheter and pump are tunneled under your skin and all wounds are surgically closed.
The pump delivers pain medication (opiates, local anesthetics, and/or muscle relaxants) directly into the intrathecal space
around the spinal cord. The medication reservoir in the pump is refilled periodically (every four to six weeks) by your pain
physician by injecting the medication through your skin into the pump.
The entire procedure typically takes one to two hours and may be performed on an outpatient or in-patient basis.
Benefits:
ITPs can be used to treat a variety of painful conditions. Nociceptive pain, or pain from tissue irritation can usually be
effectively treated with uploads like morphine. Nociceptive pain transmission is interrupted at the spinal cord and pain
relief is experienced.
Neuropathic pain, peripheral or central nervous system pain, tends to be receptive to treatments with local anesthetics
more than opioids. Examples of neuropathic pain syndromes include CRPS (complex regional pain syndrome or reflex
sympathetic dystrophy), cancer pain, phantom limb pain, post herpetic neuralgia (shingles), carpal tunnel syndrome,
failed back surgery syndrome, and peripheral neuropathy (Diabetes Mellitus, vitamin deficiencies).
Spasmodic pain can also be successfully treated by ITPs. This type of pain is effectively treated with anti-spastic muscle-
relaxing medications like Baclofen. Spasticity may be caused by impairment in the brain or spinal cord and is seen in
several conditions, such as stroke, brain injury, spinal cord injury, cerebral palsy, and multiple sclerosis (Rawlins 2004).
Spasticity is an abnormal increase in muscle tone and tightening of the muscles.
Risks:
Intrathecal pump implants are effective and safe devices used for pain management. The complications associated with
implants are mostly pharmacological and transient (Kamran). Some of the common side effects due to the medications
that are dispersed through the pump are:
• Nausea & Vomiting
• Itching
• Weakness
• Facial flushing
• Constipation
• Sleepiness
• Respiratory Depression
More serious complications that can ensue are:
• Hematoma
• Bleeding
• Infection
• Infection/Meningitis
• Catheter malfunction
ITP implants are considered an appropriate treatment for many patients who suffer from chronic difficult to control pain.
As with any medication taken, there are always risks and potential side effects that may occur. All patients receiving a
pump implant should be evaluated by their physician and risks of ITPs should be discussed.
Outcomes:
A large clinical study involving twenty four European centers showed that intrathecal pump implant therapy is clinically
effective, well tolerated and may offer improvements in pain relief and function. Muscle tone, spasm levels, and pain
intensity reductions were observed. Also cognition and motor function showed improvements (Guillaume 2005).
Intrathecal Baclofen therapy is considered safe and so effective that it has evolved into the standard treatment for severe
spasticity (Rawlins 2004). Most patients and caregivers express satisfaction with the therapy and would recommend it to
other patients. Spasm frequency appears to be the single most common variable positively affected by therapy (Vender
2006). Another study showed excellent long term efficacy in the treatment of lower extremity spasticity (Ethans 2007).
Another study observed the effects of intrathecal Morphine when delivered to patients with painful cancer. In this study all
patients and their families reported an improved quality of life with an increased level of activity, and it was deemed
“efficacious and safe” (Gilmer-Hill 1999). Another benefit with ITPs in terminal cancer is that continuous intrathecal
narcotic infusion is a very effective method to control terminal cancer pain and enables treatment in an outpatient setting
(Motsch 1988).
Pain can be a debilitating condition physically, as well as emotionally. ITPs can dramatically help those with painful
conditions that are unrelieved by other therapies. Call Arizona Pain Specialists today and see what they can do to relieve
your pain.
Journal Articles:
Intrathecal Baclofen Therapy and Multiple Sclerosis: Outcomes and Patient Satisfaction
John R. Vender, M.D.; Mary Hughes, M.D.; Betsy D. Hughes, B.S.; Sydney Hester, M.D.; Stephen Holsenback, B.S.;
Brenda Rosson, R.N. Neurosurg Focus. 2006;21(2) 2006 American Association of Neurological Surgeons
Complications of Intrathecal Drug Delivery Systems Saadat Kamran MD, Ballard D. Wright MD Department of Neurology,
Anesthesiology University of Kentucky and The Pain Treatment Center Lexington, KY
Intrathecal baclofen therapy: indications, pharmacology, surgical implant, and efficacy. Ethans K. Acta Neurochir Suppl.
2007;97(Pt 1):155-62 PMID: 17691371
A clinical study of intrathecal baclofen using a programmable pump for intractable spasticity. Guillaume D, Van
Havenbergh A, Vloeberghs M, Vidal J, Roeste G. Arch Phys Med Rehabil. 2005 Nov;86(11):2165-71
Intrathecal morphine delivered via subcutaneous pump for intractable pain in pancreatic cancer. Gilmer-Hill HS, Boggan
JE, Smith KA, Frey CF, Wagner FC Jr, Hein LJ. Surg Neurol. 1999 Jan;51(1):6-11.
Continuous intrathecal opiate therapy with a portable drug pump in cancer pain. Motsch J, Bleser W, Ismaily AJ, Distler L.
Anasth Intensivther Notfallmed. 1988 Oct;23(5):271-5.
Intrathecal baclofen therapy over 10 years. Rawlins PK. J Neurosci Nurs. 2004 Dec;36(6):322-7.
RECLAIM YOUR LIFE.
Arizona Pain Specialists 9787 N. 91st Street, Suite 101 Scottsdale, AZ. 85258 Phone: 480-563-6400
|
Arizona Pain Specialists 2007. All rights reserved
If you want more
Information about how
Arizona Pain Specialists can
help you just Click Here.
Intrathecal Pumps (ITPs)
by Nicole Berardoni M.D, Paul Lynch M.D, and Tory McJunkin M.D
Intrathecal Pumps (ITPs) are devices used in the treatment of
many chronic pain states. The pumps have shown effective in
treating cancer pain, severe back pain, neuropathic pain, and
muscle spasticity. ITPs are an automated piece of equipment that
are programmed to deliver medication into the spinal fluid through
a small catheter. This exciting pain relief technique has been
shown to be both safe and effective